What is Janux Therapeutics's PP&E (net)?

Janux Therapeutics (JANX) reported PP&E (net) of $3.55M in Q1 2026.

How has Janux Therapeutics's PP&E (net) changed year-over-year?

Janux Therapeutics's PP&E (net) decreased by 28.3% year-over-year, from $4.95M to $3.55M.

What is the long-term trend for Janux Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Janux Therapeutics's PP&E (net) has grown at a 90.1% compound annual growth rate (CAGR), from $155K to $3.85M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Janux Therapeutics JANX PP&E (Net)

PP&E (Net) at other companies

Johnson & JohnsonJNJ

$23.27B+11.5%

AmgenAMGN

$8.22B+23.0%

XencorXNCR

$51.49M-12.4%

AbbVieABBV

$5.69B+8.6%

Vor BiopharmaVOR

$565K-90.6%

Cullinan Therapeutics, Inc.CGEM

$342K-43.7%

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

P/S65×-84.6×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's PP&E (net)?: Janux Therapeutics (JANX) reported PP&E (net) of $3.55M in Q1 2026.
How has Janux Therapeutics's PP&E (net) changed year-over-year?: Janux Therapeutics's PP&E (net) decreased by 28.3% year-over-year, from $4.95M to $3.55M.
What is the long-term trend for Janux Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Janux Therapeutics's PP&E (net) has grown at a 90.1% compound annual growth rate (CAGR), from $155K to $3.85M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.